| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Pauls Dietrich John is a President And CEO at DiaMedica Therapeutics Inc.. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $401K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | DMAC Diamedica Therapeutics Inc. | President And CEO | Buy | 12,787 | $3.91 | $49,997.17 | +22.9% | -29.4% | -49.2% | |
| Nov 16, 2022 | DMAC Diamedica Therapeutics Inc. | President And CEO | Buy | 20,000 | $1.21 | $24,200.00 | +55.9% | +20.7% | +96.7% | |
| Aug 16, 2021 | DMAC Diamedica Therapeutics Inc. | President And CEO | Buy | 5,000 | $3.14 | $15,700.00 | +16.2% | +22.5% | -44.1% | |
| Aug 16, 2019 | DMAC Diamedica Therapeutics Inc. | President And CEO | Buy | 1,000 | $2.68 | $2,676.90 | +3.4% | - | - | |
| Dec 11, 2018 | DMAC Diamedica Therapeutics Inc. | President And CEO | Buy | 5,000 | $4.00 | $20,000.00 | +20.2% | - | - |